MS
VANI icon

Marshall & Sullivan’s Vivani Medical VANI Stock Holding History

Marshall & Sullivan’s Portfolio VANI Stock Details VANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-10
Closed -$2K – 62
2016
Q1 		$2K Hold
10
– – ﹤0.01% 64
2015
Q4 		$2K Hold
10
– – ﹤0.01% 64
2015
Q3 		$2K Buy
+10
New +$2.78K ﹤0.01% 63

Other funds holding VANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Marshall & Sullivan's VANI Position: Q2 2016 in Review

Marshall & Sullivan sold out of Vivani Medical (VANI) in Q2 2016, closing a stake of 10 shares — an estimated $2K sold.

Marshall & Sullivan first reported a position in VANI in Q3 2015 and held it in 3 quarters. The position peaked at $2K in Q1 2016. 57 funds tracked by Wall St. Rank hold VANI as of Q2 2016.

  • Marshall & Sullivan reported no remaining Vivani Medical position as of Q2 2016 after selling out during the quarter.
  • Marshall & Sullivan sold 10 Vivani Medical shares in Q2 2016, an estimated $2K.
  • Marshall & Sullivan first reported a position in Vivani Medical in Q3 2015 and held it in 3 quarters.
  • Marshall & Sullivan's Vivani Medical position peaked at $2K in Q1 2016.
  • 57 funds tracked by Wall St. Rank held Vivani Medical as of Q2 2016.

Based on Marshall & Sullivan's 13F filing for Q2 2016, filed 12 Aug 2016.